Clinical Trial Update: A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486 [Phase 2]

View source ↗

Summary

Phase IIa study assessing tolerance, efficacy, and safety of HSK3486 for induction of general anesthesia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Induction of General Anesthesia

Drugs mentioned

• HSK3486 (HSK3486)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Induction of General Anaesthesia | Phase 2 | Status: COMPLETED